|
humans |
28 |
|
molecular sequence data |
15 |
|
animals |
13 |
|
cell line, tumor |
13 |
|
dna methylation |
13 |
|
female |
13 |
|
male |
13 |
|
mice |
13 |
|
transfection |
13 |
|
gene silencing |
12 |
|
influenza |
12 |
|
mitosis |
12 |
|
phosphorylation |
12 |
|
amino acid sequence |
11 |
|
adaptation |
10 |
|
base sequence |
10 |
|
d222g |
10 |
|
d225g |
10 |
|
disease outbreaks |
10 |
|
epstein-barr virus |
10 |
|
h1n1 |
10 |
|
hela cells |
10 |
|
hemagglutinin |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
|
influenza, human - epidemiology - virology |
10 |
|
mutation - genetics |
10 |
|
nasopharyngeal carcinoma |
10 |
|
pandemic |
10 |
|
protein binding |
10 |
|
protein structure, tertiary |
10 |
|
sequence homology, amino acid |
10 |
|
sialic acid |
10 |
|
5' untranslated regions |
9 |
|
cpg islands - genetics |
9 |
|
disease reservoirs - virology |
9 |
|
dogs - virology |
9 |
|
picornaviridae - chemistry - classification - genetics - isolation and purification |
9 |
|
ribosomes - genetics - metabolism |
9 |
|
2009 h1n1 influenza |
8 |
|
animal experiment |
8 |
|
antibody detection |
8 |
|
dna damage |
8 |
|
flow cytometry |
8 |
|
ganglioside gm1 antibody |
8 |
|
influenza vaccine |
8 |
|
promoter regions, genetic - genetics |
8 |
|
rna interference |
8 |
|
amino acid motifs |
7 |
|
apoptosis |
7 |
|
azacitidine - analogs & derivatives - pharmacology |
7 |
|
cell cycle proteins |
7 |
|
cell cycle proteins - genetics - metabolism |
7 |
|
chfr |
7 |
|
chromatids - genetics - metabolism |
7 |
|
chromosome aberrations |
7 |
|
circular dichroism |
7 |
|
deleted in liver cancer 2 |
7 |
|
down-regulation |
7 |
|
drug resistance, neoplasm |
7 |
|
epigenesis, genetic - genetics |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
histones - metabolism |
7 |
|
lipid-binding |
7 |
|
lmp1 |
7 |
|
micelles |
7 |
|
models, molecular |
7 |
|
nasopharyngeal neoplasms - drug therapy - genetics - metabolism |
7 |
|
nasopharyngeal neoplasms - genetics - pathology |
7 |
|
neoplasm proteins - genetics - metabolism |
7 |
|
nmr |
7 |
|
nuclear magnetic resonance, biomolecular |
7 |
|
p53 |
7 |
|
phospholipids - chemistry - metabolism |
7 |
|
promoter hypermethylation |
7 |
|
proteins - antagonists & inhibitors - genetics - metabolism |
7 |
|
repressor proteins |
7 |
|
rna, messenger - genetics - metabolism |
7 |
|
sequence alignment |
7 |
|
signal transduction |
7 |
|
sodium dodecyl sulfate |
7 |
|
solutions - chemistry |
7 |
|
sterile α-motif (sam) |
7 |
|
structures |
7 |
|
tumor cells, cultured |
7 |
|
tumor suppressor proteins - chemistry - genetics - metabolism |
7 |
|
adeno-associated virus |
6 |
|
aged |
6 |
|
cell line |
6 |
|
gene expression regulation, neoplastic |
6 |
|
mice, nude |
6 |
|
reverse transcriptase polymerase chain reaction |
6 |
|
3t3 cells |
5 |
|
actins - metabolism |
5 |
|
calcium-binding proteins - physiology |
5 |
|
cccdna |
5 |
|
cell movement |
5 |
|
cell proliferation |
5 |
|
cell shape |
5 |
|
cell transformation, neoplastic |
5 |
|
coronavirus |
5 |
|
down-regulation - genetics |
5 |
|
emerging infectious disease |
5 |
|
epithelial cells - metabolism - pathology |
5 |
|
fibroblasts - cytology - physiology |
5 |
|
gtpase-activating proteins - genetics - metabolism |
5 |
|
hbx |
5 |
|
hepatitis b virus |
5 |
|
mad2 |
5 |
|
microtubules |
5 |
|
microtubules - metabolism - pathology |
5 |
|
middle aged |
5 |
|
nasopharyngeal epithelial cells |
5 |
|
nf-κb |
5 |
|
protein isoforms - genetics - metabolism |
5 |
|
rassf1a |
5 |
|
rhoa gtp-binding protein - antagonists & inhibitors - metabolism |
5 |
|
rna virus |
5 |
|
sirt1 |
5 |
|
sirtuin |
5 |
|
tumor suppressor proteins - antagonists and inhibitors - biosynthesis - genetics |
5 |
|
tumor suppressor proteins - genetics - metabolism |
5 |
|
virus activation - physiology |
5 |
|
virus evolution |
5 |
|
adaptor proteins, signal transducing - metabolism |
4 |
|
adult |
4 |
|
antineoplastic agents - pharmacology |
4 |
|
apoptosis - drug effects |
4 |
|
asia, southeastern - epidemiology |
4 |
|
bone marrow - pathology |
4 |
|
carcinoma - epidemiology - etiology - virology |
4 |
|
carcinoma, hepatocellular - genetics |
4 |
|
carcinoma, hepatocellular - genetics - metabolism |
4 |
|
carcinoma, hepatocellular - pathology |
4 |
|
cdc42 gtp-binding protein - metabolism |
4 |
|
cell line, transformed |
4 |
|
cell movement - physiology |
4 |
|
cell transplantation |
4 |
|
centrosome |
4 |
|
centrosome - metabolism - pathology |
4 |
|
chromosome fragility - genetics |
4 |
|
chromosomes, human, pair 13 |
4 |
|
cleavage of s protein |
4 |
|
clone cells - pathology |
4 |
|
cyclin-dependent kinase inhibitor p16 - biosynthesis |
4 |
|
disease progression |
4 |
|
dna primers - genetics |
4 |
|
dna, neoplasm - analysis |
4 |
|
dna-binding proteins - analysis - genetics |
4 |
|
drug susceptibility |
4 |
|
epigenesis, genetic |
4 |
|
epigenesis, genetic - drug effects - physiology |
4 |
|
epithelial cells - metabolism - virology |
4 |
|
epithelial cells - virology |
4 |
|
epstein-barr virus infections - complications |
4 |
|
epstein-barr virus infections - genetics |
4 |
|
factor xa - metabolism |
4 |
|
g2 phase |
4 |
|
g2/m cell cycle |
4 |
|
gene expression |
4 |
|
gene expression regulation, neoplastic - drug effects |
4 |
|
gene expression regulation, viral |
4 |
|
gene silencing - drug effects - physiology |
4 |
|
genes, p16 |
4 |
|
genes, tumor suppressor |
4 |
|
gtpase-activating proteins - chemistry - genetics - physiology |
4 |
|
gtpase-activating proteins - genetics |
4 |
|
herpesvirus 4, human - isolation & purification |
4 |
|
herpesvirus 4, human - physiology |
4 |
|
hong kong - epidemiology |
4 |
|
hypermethylation |
4 |
|
id1 |
4 |
|
incidence |
4 |
|
inhibitor of differentiation protein 1 |
4 |
|
interferon type i - genetics - immunology |
4 |
|
kidney - virology |
4 |
|
liver neoplasms - genetics |
4 |
|
liver neoplasms - genetics - metabolism |
4 |
|
loss of heterozygosity |
4 |
|
membrane glycoproteins - metabolism |
4 |
|
microrna |
4 |
|
micrornas - genetics |
4 |
|
mir203 |
4 |
|
mitosis - drug effects |
4 |
|
mitotic checkpoint |
4 |
|
mitotic index |
4 |
|
mitotic spindle apparatus |
4 |
|
modelling |
4 |
|
multiple myeloma - etiology - genetics |
4 |
|
multiple myeloma - genetics - pathology |
4 |
|
myeloma |
4 |
|
nasopharyngeal neoplasms - epidemiology - etiology - virology |
4 |
|
nasopharyngeal neoplasms - epidemiology - genetics - pathology |
4 |
|
nasopharynx - cytology |
4 |
|
nasopharynx - virology |
4 |
|
neoplasm proteins |
4 |
|
nf-kappa b - physiology |
4 |
|
nocodazole - pharmacology |
4 |
|
nuclear factor κb |
4 |
|
oxidation-reduction |
4 |
|
peroxidases - genetics - metabolism - pharmacology |
4 |
|
peroxiredoxin |
4 |
|
peroxiredoxin iii |
4 |
|
peroxiredoxins |
4 |
|
phylogeny |
4 |
|
primary cell culture |
4 |
|
prostate cancer |
4 |
|
prostatic neoplasms |
4 |
|
protease factor xa |
4 |
|
protease inhibitor |
4 |
|
rac1 gtp-binding protein - metabolism |
4 |
|
reactive oxygen species (ros) |
4 |
|
reactive oxygen species - metabolism |
4 |
|
recurrence |
4 |
|
redox |
4 |
|
replication capacity |
4 |
|
rhoa gtp-binding protein - metabolism |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
rna, messenger - metabolism |
4 |
|
rna, viral - analysis |
4 |
|
sars virus - immunology |
4 |
|
sars-cov |
4 |
|
sequence deletion |
4 |
|
severe acute respiratory syndrome - immunology - virology |
4 |
|
smad2 protein |
4 |
|
spike protein |
4 |
|
staining and labeling |
4 |
|
thioredoxin peroxidase |
4 |
|
trans-activators - analysis - genetics |
4 |
|
transcription factors - biosynthesis - genetics - physiology |
4 |
|
transcription, genetic |
4 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
4 |
|
tumor suppressor protein p53 - metabolism - pharmacology |
4 |
|
tumor suppressor proteins - genetics - physiology |
4 |
|
tumour suppressor |
4 |
|
viral envelope proteins - metabolism |
4 |
|
viral matrix proteins - chemistry - physiology |
4 |
|
viral matrix proteins - immunology - metabolism |
4 |
|
virus replication - physiology |
4 |
|
abca1 |
3 |
|
adult t-cell leukemia |
3 |
|
age of onset |
3 |
|
aged, 80 and over |
3 |
|
alleles |
3 |
|
alzheimer disease - diagnosis - epidemiology - genetics |
3 |
|
alzheimer disease - ethnology - genetics |
3 |
|
alzheimer's disease |
3 |
|
antibody formation - immunology |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
apolipoprotein e4 - genetics |
3 |
|
apoptosis - drug effects - physiology |
3 |
|
asian continental ancestry group - genetics |
3 |
|
association |
3 |
|
atf4 |
3 |
|
atp-binding cassette transporters - genetics |
3 |
|
bcl-2 |
3 |
|
benzopyrans - pharmacology |
3 |
|
blotting, western |
3 |
|
calcium-binding proteins - biosynthesis - genetics |
3 |
|
calcium-binding proteins - metabolism - physiology |
3 |
|
carcinogenesis |
3 |
|
carcinoma, hepatocellular - enzymology - genetics - metabolism - pathology |
3 |
|
carcinoma, hepatocellular - metabolism |
3 |
|
carrier proteins |
3 |
|
case-control |
3 |
|
case-control studies |
3 |
|
caspase 3 |
3 |
|
caspases - antagonists & inhibitors - metabolism |
3 |
|
cd4-positive t-lymphocytes - immunology |
3 |
|
cd8-positive t-lymphocytes - immunology |
3 |
|
cell cycle control |
3 |
|
cell cycle proteins - analysis - genetics - physiology |
3 |
|
cell nucleus - chemistry |
3 |
|
cells, cultured |
3 |
|
china - epidemiology |
3 |
|
chinese |
3 |
|
cholesterol metabolism |
3 |
|
chromosomal instability |
3 |
|
cisplatin - pharmacology |
3 |
|
crispr/cas9 |
3 |
|
cyp46a 1 |
3 |
|
cytoplasm - chemistry |
3 |
|
dependovirus - genetics - immunology |
3 |
|
dna mutational analysis |
3 |
|
ebna1 |
3 |
|
ecdysterone - analogs & derivatives - pharmacology |
3 |
|
eif2α |
3 |
|
enzyme activation |
3 |
|
enzyme inhibitors - pharmacology |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
epitopes - immunology |
3 |
|
ets-domain protein elk-1 - metabolism |
3 |
|
faci |
3 |
|
fungal proteins - physiology |
3 |
|
gene expression regulation |
3 |
|
gene knockdown techniques |
3 |
|
genetic predisposition to disease |
3 |
|
genome |
3 |
|
genome instability |
3 |
|
genotype |
3 |
|
haplotype |
3 |
|
haplotypes |
3 |
|
hbz |
3 |
|
hepatocellular carcinoma |
3 |
|
high-fat diet |
3 |
|
human t-cell leukemia virus type 1 |
3 |
|
humanized mouse model |
3 |
|
immune responses |
3 |
|
immunity, cellular - immunology |
3 |
|
immunization schedule |
3 |
|
immunization, secondary |
3 |
|
immunoglobulin g - analysis - biosynthesis |
3 |
|
influenza a virus |
3 |
|
innate antiviral response |
3 |
|
internal ribosome entry site (ires) |
3 |
|
introns - genetics |
3 |
|
jnk mitogen-activated protein kinases - metabolism |
3 |
|
linkage disequilibrium |
3 |
|
liver neoplasms - enzymology - genetics - metabolism - pathology |
3 |
|
liver neoplasms - metabolism |
3 |
|
liver neoplasms - metabolism - pathology |
3 |
|
liver neoplasms - pathology |
3 |
|
membrane glycoproteins - administration and dosage - genetics - immunology |
3 |
|
metabolic syndrome |
3 |
|
mice, inbred balb c |
3 |
|
microfilament proteins - genetics - metabolism |
3 |
|
microscopy, fluorescence |
3 |
|
microtubule toxin |
3 |
|
microtubules - metabolism |
3 |
|
mitogen-activated protein kinases - metabolism |
3 |
|
mitosis - drug effects - physiology |
3 |
|
myeloid-lymphoid leukemia protein - metabolism |
3 |
|
nasopharyngeal neoplasms - drug therapy - genetics - metabolism - pathology |
3 |
|
nasopharyngeal neoplasms - pathology |
3 |
|
neoplasm invasiveness |
3 |
|
neoplasm metastasis |
3 |
|
neutralization tests |
3 |
|
nitriles - pharmacology |
3 |
|
nuclear proteins |
3 |
|
nuclear proteins - analysis - genetics - physiology |
3 |
|
oncogene proteins, fusion - metabolism |
3 |
|
p21-activated kinases |
3 |
|
pact |
3 |
|
paxillin - metabolism |
3 |
|
peptides to t cell epitopes |
3 |
|
phosphoprotein phosphatases - metabolism |
3 |
|
phosphoric monoester hydrolases - genetics - metabolism |
3 |
|
polymerase chain reaction |
3 |
|
polymorphism |
3 |
|
polymorphism, genetic - genetics |
3 |
|
polymorphism, single nucleotide |
3 |
|
protein isoforms |
3 |
|
protein-serine-threonine kinases - biosynthesis - genetics - metabolism |
3 |
|
proto-oncogene proteins c-bcl-2 - antagonists & inhibitors |
3 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
3 |
|
proto-oncogene proteins c-raf - metabolism |
3 |
|
quantitative trait, heritable |
3 |
|
raf |
3 |
|
ras proteins - metabolism |
3 |
|
receptor binding domain |
3 |
|
receptors, virus - genetics - immunology |
3 |
|
repressor proteins - physiology |
3 |
|
rig-i |
3 |
|
rna, messenger - analysis |
3 |
|
sars virus - drug effects - physiology |
3 |
|
severe acute respiratory syndrome - immunology - prevention & control - virology |
3 |
|
severe acute respiratory syndrome - prevention and control |
3 |
|
single nucleotide polymorphisms (snp) |
3 |
|
spindle assembly checkpoint |
3 |
|
steroid hydroxylases - genetics |
3 |
|
t-lymphocytes - immunology |
3 |
|
tax |
3 |
|
time factors |
3 |
|
translation initiation |
3 |
|
tumor markers, biological - genetics - metabolism |
3 |
|
type i interferons |
3 |
|
unfolded protein response |
3 |
|
upstream open reading frame |
3 |
|
vaccines, synthetic - immunology |
3 |
|
vincristine |
3 |
|
vincristine - pharmacology |
3 |
|
viral envelope proteins - administration and dosage - genetics - immunology |
3 |
|
viral matrix proteins - genetics - immunology |
3 |
|
viral vaccines - administration and dosage - genetics - immunology |
3 |
|
viral vaccines - immunology |
3 |
|
activating transcription factor 4 - genetics - metabolism |
2 |
|
allelic expression |
2 |
|
alternative splicing |
2 |
|
alzheimer disease - diagnosis - enzymology - genetics |
2 |
|
anaphase - physiology |
2 |
|
anaphase-promoting complex (apc) |
2 |
|
cancer |
2 |
|
case-control study |
2 |
|
cdh1 |
2 |
|
cell cycle - drug effects |
2 |
|
cell cycle - physiology |
2 |
|
cell cycle arrest |
2 |
|
cell cycle proteins - chemistry |
2 |
|
cell nucleus - metabolism |
2 |
|
cell-cycle control |
2 |
|
centrosome - metabolism |
2 |
|
cercopithecus aethiops |
2 |
|
chemotherapy |
2 |
|
chromosome mapping |
2 |
|
chromosome segregation |
2 |
|
chromosomes, human, pair 7 |
2 |
|
cloning, molecular |
2 |
|
cyclic amp response element-binding protein - genetics - metabolism |
2 |
|
cyclin a - metabolism |
2 |
|
cyclin degradation |
2 |
|
cyclin e - metabolism |
2 |
|
cyp46a1 |
2 |
|
dead-box rna helicases - immunology - metabolism |
2 |
|
eif-2 kinase - metabolism - physiology |
2 |
|
electrophoresis, polyacrylamide gel |
2 |
|
escherichia coli - enzymology - genetics |
2 |
|
fungal proteins - genetics - physiology |
2 |
|
g1 phase |
2 |
|
gene deletion |
2 |
|
gene expression regulation, fungal |
2 |
|
gene expression regulation, viral - physiology |
2 |
|
gene products, tax - genetics - metabolism |
2 |
|
genetic predisposition to disease - genetics |
2 |
|
genomic instability |
2 |
|
haplotypes - genetics |
2 |
|
hek293 cells |
2 |
|
human t-lymphotropic virus 1 - physiology |
2 |
|
immunity, innate |
2 |
|
interferon type i - biosynthesis |
2 |
|
interphase - physiology |
2 |
|
ligases - biosynthesis - genetics - metabolism - physiology |
2 |
|
ligases - metabolism |
2 |
|
metaphase - physiology |
2 |
|
methyltransferases - genetics |
2 |
|
neoplasms - drug therapy - metabolism - pathology |
2 |
|
nuclear localization signals - metabolism |
2 |
|
nuclear proteins - chemistry - metabolism |
2 |
|
nuclear proteins - genetics |
2 |
|
oxidative stress - genetics |
2 |
|
p300-cbp transcription factors - genetics - metabolism |
2 |
|
peroxidases - genetics |
2 |
|
phosphoproteins - deficiency - genetics - metabolism |
2 |
|
plasmids - genetics |
2 |
|
poly i-c - immunology |
2 |
|
polymorphism, single nucleotide - genetics |
2 |
|
protein binding - physiology |
2 |
|
protein isoforms - biosynthesis - genetics - metabolism - physiology |
2 |
|
protein-arginine n-methyltransferases - genetics - metabolism |
2 |
|
proteins - genetics - physiology |
2 |
|
repressor proteins - genetics - metabolism |
2 |
|
risk factors |
2 |
|
rna, double-stranded - metabolism |
2 |
|
rna, small interfering |
2 |
|
rna-binding proteins - chemistry - metabolism |
2 |
|
rna-binding proteins - metabolism |
2 |
|
saccharomyces cerevisiae - physiology |
2 |
|
saccharomyces cerevisiae proteins |
2 |
|
saccharomyces cerevisiae proteins - metabolism |
2 |
|
sequence homology |
2 |
|
signal transduction - physiology |
2 |
|
taxoids - pharmacology |
2 |
|
terminal repeat sequences - physiology |
2 |
|
trans-activators - genetics - metabolism |
2 |
|
transcription factors - deficiency - genetics - metabolism |
2 |
|
transcription, genetic - physiology |
2 |
|
ubiquitin-protein ligase complexes |
2 |
|
vero cells |
2 |
|
viruses - immunology - metabolism |
2 |
|
xenopus embryonic cell cycles |
2 |
|
xenopus laevis - embryology |
2 |
|
alpha 1-antitrypsin - genetics |
1 |
|
arteriosclerosis - genetics |
1 |
|
autophagy |
1 |
|
b cell lymphoma |
1 |
|
basic helix-loop-helix transcription factors |
1 |
|
beta-galactosidase - genetics - metabolism |
1 |
|
brain - metabolism |
1 |
|
bunyavirus |
1 |
|
calcium-binding proteins - genetics |
1 |
|
carcinoma, hepatocellular - genetics - virology |
1 |
|
cell survival |
1 |
|
chemokine ccl4 |
1 |
|
chloramphenicol o-acetyltransferase - genetics - metabolism |
1 |
|
chromosomes, human, pair 4 |
1 |
|
creb |
1 |
|
crosses, genetic |
1 |
|
cyclic amp response element-binding protein - metabolism - physiology |
1 |
|
dimerization |
1 |
|
dna sequencing |
1 |
|
emerging pathogens |
1 |
|
fusion oncoprotein |
1 |
|
gene expression - genetics |
1 |
|
gene expression regulation, leukemic |
1 |
|
gene products, pol - genetics - metabolism |
1 |
|
gene products, tax - chemistry - metabolism |
1 |
|
gene targeting |
1 |
|
genes, cdc |
1 |
|
genes, viral |
1 |
|
genetic complementation test |
1 |
|
genetic markers |
1 |
|
hcc |
1 |
|
hcv |
1 |
|
hepacivirus - genetics - pathogenicity - physiology |
1 |
|
hepatic fibrosis |
1 |
|
hepatic steatosis |
1 |
|
hepatitis c virus |
1 |
|
hepatitis c, chronic - virology |
1 |
|
histone deacetylase 1 |
1 |
|
histone deacetylases - physiology |
1 |
|
hiv - genetics - metabolism |
1 |
|
hiv infections - immunology |
1 |
|
hiv-1 |
1 |
|
human t-cell leukemia virus type i oncoprotein tax |
1 |
|
hydrogen peroxide - metabolism |
1 |
|
hydrolysis |
1 |
|
hydroxamic acids - pharmacology |
1 |
|
in situ hybridization, fluorescence |
1 |
|
infant |
1 |
|
innate immunity |
1 |
|
introns |
1 |
|
isoenzymes - genetics |
1 |
|
leukemia, myeloid, acute - metabolism |
1 |
|
liver neoplasms - genetics - virology |
1 |
|
macrophage inflammatory proteins - metabolism |
1 |
|
mir-342-3p |
1 |
|
models, biological |
1 |
|
models, chemical |
1 |
|
mutagenesis, site-directed - genetics |
1 |
|
mutation |
1 |
|
neoplasms - etiology - metabolism |
1 |
|
nonstructural protein |
1 |
|
oncogenesis |
1 |
|
oxidative stress |
1 |
|
peptide fragments - genetics |
1 |
|
phlebovirus |
1 |
|
phosphoproteins - genetics |
1 |
|
plasmids |
1 |
|
point mutation - genetics |
1 |
|
promoter regions, genetic |
1 |
|
protein processing, post-translational |
1 |
|
protein-serine-threonine kinases - metabolism |
1 |
|
proto-oncogene |
1 |
|
receptors, ccr5 - genetics - physiology |
1 |
|
recombination, genetic |
1 |
|
repressor proteins - genetics - physiology |
1 |
|
response elements |
1 |
|
review |
1 |
|
rna, catalytic - genetics - metabolism |
1 |
|
rna, viral - genetics - metabolism |
1 |
|
saccharomyces cerevisiae |
1 |
|
saccharomyces cerevisiae - genetics |
1 |
|
sequence analysis |
1 |
|
sequence deletion - genetics |
1 |
|
serine proteinase inhibitors |
1 |
|
serpin superfamily |
1 |
|
torc coactivators |
1 |
|
transcription factors - physiology |
1 |
|
transcriptional activation - genetics |
1 |
|
tumor suppressor mirna |
1 |
|
tumor suppressor protein p53 - physiology |
1 |
|
vaccinia virus |
1 |
|
vaccinia virus - enzymology - genetics |
1 |
|
viral proteins - chemistry - metabolism |
1 |
|
virion - genetics - physiology |
1 |
|
virus assembly - genetics |
1 |
|
virus-host interaction |
1 |
|
zinc fingers - genetics |
1 |
|
分子生物学 |
1 |
|
前沿领域 |
1 |
|
干扰素 |
1 |
|
病毒 |
1 |
|
诱生 |
1 |
